Glucocorticoid-induced apoptosis requires FOXO3A activity

Jiexian Ma1, Yanhui Xie, Yi Shi

  • 1The Hematology Department of Huashan Hospital Affiliated in Fudan University, Shanghai 200040, China.

Insights

Dexamethasone (DEX) triggers apoptosis in lymphocytes by activating the FOXO3A transcription factor. Cancer cells resist DEX-induced apoptosis, potentially due to higher levels of phosphorylated FOXO3A.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Dexamethasone (DEX) is known to induce apoptosis in lymphocytes and protect certain cancer cells.
  • The precise molecular mechanisms underlying DEX's effects on apoptosis remain incompletely understood.
  • The forkhead transcription factor FOXO3A plays a role in regulating apoptosis.

Purpose of the Study:

  • To investigate the role of FOXO3A in dexamethasone (DEX)-induced apoptosis.
  • To explore the differential regulation of FOXO3A activity in lymphocytes versus cancer cells following DEX treatment.

Main Methods:

  • Examined FOXO3A expression and phosphorylation status in lymphocytes and cancer cells after DEX treatment.
  • Utilized small interfering RNA (siRNA) to knock down FOXO3A expression in lymphocytes.
  • Correlated DEX sensitivity with phospho-FOXO3A levels in various cancer cell lines.

Main Results:

  • DEX treatment upregulated total FOXO3A and downregulated phospho-FOXO3A in lymphocytes, indicating activation of the unphosphorylated form.
  • Sensitivity to DEX in cancer cells negatively correlated with the expression of phospho-FOXO3A.
  • Knockdown of FOXO3A significantly reduced DEX-induced apoptosis in lymphocytes.

Conclusions:

  • FOXO3A is a key mediator of DEX-induced apoptosis in lymphocytes.
  • DEX appears to promote apoptosis by maintaining FOXO3A in its active, unphosphorylated state.
  • Elevated phospho-FOXO3A levels in cancer cells may contribute to their resistance to DEX, suggesting FOXO3A as a potential therapeutic target.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...